FrancophonIA/ELRC3.0 huggingface dataset:
English: The most common side effects with Glustin (seen in between 1 and 10 patients in 100) are upper respiratory tract infection (colds), hypoaesthesia (reduced sense of touch), visual disturbance, bone fractures and increased weight.
Croatian: Najčešće nuspojave lijeka Glustin (uočene između 1 i 10 na 100 bolesnika) su infekcija gornjih dišnih puteva (prehlada), hipoestezija (smanjenje osjećaja dodira), poremećaj vida i povećanje tjelesne težine.
English: Almost 7,000 patients received Glustin in all of the studies combined.
Croatian: U svim ispitivanjima gotovo je 7 000 bolesnika primilo lijek Glustin.
English: The company that markets Glustin will produce educational material for doctors prescribing the medicine, which will cover the possible risk of heart failure and bladder cancer with treatments that contain pioglitazone, the criteria for selecting patients and the need to review treatment regularly and stop treatment if patients are no longer benefiting.
Croatian: Tvrtka koja lijek Glustin stavlja u promet osigurat će edukativne materijale za liječnike koji propisuju taj lijek, a koji će obuhvaćati informacije o mogućem riziku od srčanog zastoja i raka mjehura u primjeni terapija koje sadrže pioglitazon, kriterijima za odabir pacijenata te potrebi za redovitim procjenjivanjem učinaka terapije i prekidu liječenja u slučaju kada bolesnici više nemaju koristi od nje.
English: Glustin is used to treat type 2 diabetes in adults (aged 18 years or over), particularly those who are overweight.
Croatian: Lijek Glustin primjenjuje se za liječenje dijabetesa tipa 2 u odraslih osoba (u dobi od 18 godina i starijih), osobito u onih prekomjerne tjelesne težine.
English: The doses of Glustin may need to be adjusted when given with some other medicines such as gemfibrozil (used to lower cholesterol) or rifampicin (an antibiotic used to treat tuberculosis).
Croatian: Možda će biti potrebno prilagoditi doze lijeka Glustin ako se primjenjuje s drugim lijekovima kao što su gemfibrozil (lijek za snižavanje kolesterola) ili rifampicin (antibiotik za liječenje tuberkuloze).
English: If Glustin is used in combination with other diabetes medicines, other side effects may occur.
Croatian: Ako se lijek Glustin koristi u kombinaciji s drugim lijekovima protiv dijabetesa, mogu se pojaviti druge nuspojave.
English: The studies measured the level of a substance in the blood called glycosylated haemoglobin (HbA1c), which gives an indication of how well the blood glucose is controlled.
Croatian: Ispitivanja su mjerila koncentraciju tvari zvane glikozilirani hemoglobin (HbA1c) u krvi, koja pokazuje koliko se dobro kontrolira glukoza u krvi.
English: What is Glustin?
Croatian: Što je Glustin?
English: Glustin must not be used in patients who have problems with their liver, patients who have had heart failure (when the heart does not work as well as it should) or patients with diabetic ketoacidosis (a complication of diabetes).
Croatian: Lijek Glustin ne smije se primjenjivati u bolesnika koji imaju problema s jetrom, bolesnika koji su imali srčani zastoj (kada srce ne radi kako bi trebalo) ili u bolesnika s dijabetičkom ketoacidozom (komplikacija uzrokovana dijabetesom).
English: Type 2 diabetes is a disease in which the pancreas does not make enough insulin to control the level of glucose in the blood or when the body is unable to use insulin effectively.
Croatian: Dijabetes tipa 2 bolest je pri kojoj gušterača ne proizvodi dovoljno inzulina za kontrolu razine glukoze u krvi ili pri kojoj tijelo ne može učinkovito koristiti inzulin.
English: At subsequent reviews prescribers should confirm that benefits to patients are maintained.
Croatian: U naknadnim ponovnim procjenama liječnici koji propisuju terapiju moraju potvrditi da su se održale koristi u bolesnika.
English: What is the risk associated with Glustin?
Croatian: Koji su rizici povezani s lijekom Glustin?
English: The CHMP decided that Glustin's benefits are greater than its risks and recommended that it be given marketing authorisation.
Croatian: CHMP je odlučio da koristi od lijeka Glustin nadmašuju s njim povezane rizike te je preporučio izdavanje odobrenja za stavljanje lijeka u promet.
English: The active substance in Glustin, pioglitazone, makes cells (fat, muscle and liver) more sensitive to insulin, which means that the body makes better use of the insulin it produces.
Croatian: Pioglitazon, djelatna tvar u lijeku Glustin, čini stanice (masti, mišića i jetre) osjetljivijima na inzulin, što znači da tijelo u većoj mjeri koristi inzulin koji proizvodi.
English: Treatment with Glustin should be reviewed after three to six months, and discontinued in patients who are not deriving sufficient benefit.
Croatian: Nakon tri do šest mjeseci liječenja potrebno je procijeniti učinke terapije lijekom Glustin i prekinuti liječenje u bolesnika kod kojih nisu vidljive dostatne koristi.
English: • in combination with metformin in patients who are not satisfactorily controlled on metformin alone, or with a sulphonylurea (another type of diabetes medicine) when metformin is not suitable in patients who are not satisfactorily controlled on a sulphonylurea alone;
Croatian: • u kombinaciji s metforminom u bolesnika koji ne mogu postići zadovoljavajuću kontrolu samo metforminom ili sa sulfonilurejom (drugom vrstom lijeka protiv dijabetesa) kada primjena metformina nije primjerena u bolesnika koji ne mogu postići zadovoljavajuću kontrolu samo sulfonilurejom;
English: Why has Glustin been approved?
Croatian: Zašto je lijek Glustin odobren?
English: Glustin also improved the glucose control obtained in type 2 diabetes when it was added to existing treatment with a sulphonylurea, insulin or metformin, or the combination of metformin and a sulphonylurea.
Croatian: Lijek Glustin također je poboljšao postignutu kontrolu glukoze kod dijabetesa tipa 2 kada je dodan postojećem liječenju sulfonilurejom, inzulinom ili metmorfinom ili liječenju kombinacijom metmorfina i sulfonilureje.
English: • on its own in patients for whom metformin (another diabetes medicine) is not suitable;
Croatian: • kao monoterapija u bolesnika u kojih primjena metformina (drugog lijeka protiv dijabetesa) nije primjerena;
English: • together with both metformin and a sulphonylurea in patients who are not satisfactorily controlled despite treatment with two medicines by mouth;
Croatian: • u kombinaciji s metforminom i sulfonilurejom u bolesnika koji ne mogu postići zadovoljavajuću kontrolu, unatoč oralnom liječenju dvama lijekovima;
English: Some studies also looked at combining Glustin with a sulphonylurea, insulin or metformin, or with the combination of metformin and a sulphonylurea.
Croatian: U pojedinim se ispitivanjima proučavalo i kombiniranje lijeka Glustin sa sulfonilurejom, inzulinom ili metforminom ili s kombinacijom metformina i sulfonilureje.
English: Glustin led to a decrease in the level of HbA1c, indicating that blood glucose levels had been reduced at doses of 15, 30 and 45 mg. Glustin on its own was shown to be as effective as metformin and gliclazide.
Croatian: Lijek Glustin smanjio je razinu tvari HbA1c, što pokazuje da su razine glukoze u krvi smanjene na doze od 15, 30 i 45 mg.
English: What is Glustin used for?
Croatian: Za što se Glustin koristi?
English: • together with insulin in patients who are not satisfactorily controlled with insulin alone and cannot take metformin.
Croatian: • u kombinaciji s inzulinom u bolesnika koji ne mogu postići zadovoljavajuću kontrolu samo inzulinom i koji ne smiju uzimati metmorfin.
English: For the full list of all side effects reported with Glustin, see the package leaflet.
Croatian: Potpuni popis svih nuspojava zabilježenih pri primjeni lijeka Glustin potražite u uputi o lijeku.
English: Glustin has been compared with placebo (a dummy treatment), metformin and gliclazide (a sulphonylurea) in a number of studies.
Croatian: Glustin je u brojnim ispitivanjima uspoređen s placebom (prividno liječenje), metforminom i gliklazidom (sulfonilurejom).
English: How is Glustin used?
Croatian: Kako se Glustin koristi?
English: What benefit has Glustin shown during the studies?
Croatian: Koje su koristi lijeka Glustin utvrđene u ispitivanjima?
English: Recommendations and precautions to be followed by healthcare professionals and patients for the safe and effective use of Glustin have also been included in the summary of product characteristics and the package leaflet.
Croatian: U sažetku opisa svojstava lijeka i uputi o lijeku također se nalaze preporuke i mjere opreza za sigurnu i učinkovitu primjenu lijeka Glustin kojih se zdravstveni djelatnici i bolesnici trebaju pridržavati.
English: How does Glustin work?
Croatian: Kako djeluje Glustin?
English: How has Glustin been studied?
Croatian: Kako je lijek Glustin ispitivan?
English: 6 Month 20191
Croatian: 6 May 20191
English: Mean follow-up was 569 days.
Croatian: Srednja vrijednost razdoblja praćenja iznosila je 569 dana.
English: [Product name] should not be used during pregnancy.
Croatian: [Naziv lijeka] se ne smije primjenjivati tijekom trudnoće.
English: Special warnings and precautions for use
Croatian: 4.4 Posebna upozorenja i mjere opreza pri uporabi
English: As modafinil may reduce the effectiveness of oral contraception alternative additional methods of contraception are required (see sections 4.4 and 4.5).
Croatian: S obzirom da modafinil može smanjiti učinkovitost oralne kontracepcije, potrebne su druge dodatne metode kontracepcije (vidjeti dijelove 4.4 i 4.5).
English: What you need to know before you take Eliquis/Lixiana/Roteas Warnings and precautions
Croatian: Što morate znati prije nego počnete uzimati Eliquis/Lixianu/Roteas Upozorenja i mjere opreza
English: Adopted at the 8-11 April 2019 PRAC
Croatian: Usvojeno na sjednici PRAC-a 8. - 11. travnja 2019.
English: Women of childbearing potential have to use effective contraception.
Croatian: Žene u reproduktivnoj dobi moraju koristiti učinkovitu kontracepciju.
English: These may cause increased blood levels of [active substance].
Croatian: Ovi lijekovi mogu uzrokovati povišenje razine [djelatna tvar] u krvi.
English: Patients with high risk triple positive antiphospholipid syndrome
Croatian: Bolesnici s visokorizičnim trostruko pozitivnim antifosfolipidnim sindromom
English: Modafinil is not recommended for use during pregnancy or in women of childbearing potential unless they are using effective contraception.
Croatian: Liječenje modafinilom se ne preporučuje tijekom trudnoće i u žena reproduktivne dobi osim ako koriste učinkovitu kontracepciju.
English: Based on limited human experience from a pregnancy registry and spontaneous reporting modafinil is suspected to cause congenital malformations when administered during pregnancy.
Croatian: Ograničena iskustva u ljudi, koja se temelje na registru trudnoća i spontanom prijavljivanju, ukazuju na to da modafinil uzrokuje kongenitalne malformacije ako se primjenjuje tijekom trudnoće.
English: Modafinil - Evaluation of data on foetal outcomes including congenital anomalies from a single observational study in the US (EPITT no 19367)
Croatian: Modafinil - evaluacija podataka o ishodima trudnoća za fetus, uključujući kongenitalne anomalije iz opservacijskog ispitivanja provedenog u SAD-u (EPITT br. 19367)
English: The trial was terminated prematurely after the enrolment of 120 patients due to an excess of events among patients in the rivaroxaban arm.
Croatian: Ispitivanje je nakon uključivanja 120 bolesnika završeno prijevremeno zbog velikog broja događaja u skupini koja je primala rivaroksaban.
English: What you need to know before you take [product name] Pregnancy and breast-feeding
Croatian: Što morate znati prije nego počnete uzimati [naziv lijeka] Trudnoća i dojenje
English: Modafinil is suspected to cause birth defects if taken during pregnancy.
Croatian: Modafinil može uzrokovati urođene mane ako se uzima tijekom trudnoće.
English: There is limited data on the use of modafinil in pregnant women.
Croatian: Dostupni su ograničeni podaci o primjeni modafinila u trudnica.
English: A reduction in the dose of [active substance] may be necessary based on monitoring of side-effects during concomitant treatment (see section 4.4).
Croatian: Možda će biti potrebno smanjiti dozu [djelatna tvar] na temelju praćenja nuspojava tijekom istodobnog liječenja (vidjeti dio
English: 59 patients were randomized to rivaroxaban 20 mg (15 mg for patients with creatinine clearance (CrCl) <50 mL/min) and 61 to warfarin (INR 2.0- 3.0).
Croatian: U skupinu koja je primala 20 mg rivaroksabana randomizirano je 59 ispitanika (15 mg u bolesnika s klirensom kreatinina <50 ml/min), a u skupinu koja je primala varfarin 61 bolesnik (INR 2,0 - 3,0).
English: Thromboembolic events occurred in 12% of patients randomized to rivaroxaban (4 ischaemic strokes and 3 myocardial infarctions).
Croatian: Tromboembolijski događaji pojavili su se u 12% bolesnika randomiziranih u skupinu koja je primala rivaroksaban (4 ishemijska moždana udara i 3 infarkta miokarda).
English: What you need to know before you take Xarelto/Pradaxa Take special care with Xarelto/Pradaxa - if you know that you have a disease called antiphospholipid syndrome (a disorder of the immune system that causes an increased risk of blood clots), tell your doctor who will decide if the treatment may need to be changed.
Croatian: Što morate znati prije nego počnete uzimati [naziv lijeka]/Xarelto/Pradaxa Budite posebno oprezni s [naziv lijeka]/Xarelto/Pradaxa - ako znate da imate bolest koja se naziva antifosfolipidni sindrom (poremećaj imunološkog sustava koji uzrokuje povećani rizik od nastanka krvnih ugrušaka), obavijestite o tome svog liječnika koji će odlučiti postoji li potreba za izmjenom terapije.
English: Cimetidine, lansoprazole and omeprazole (used to treat stomach ulcers), fluconazole (used to treat fungal infections), fluvoxamine (antidepressant) and ticlopidine (used to reduce the risk of stroke).
Croatian: Cimetidin, lanzoprazol i omeprazol (koriste se za liječenje čireva na želucu), flukonazol (koristi se za liječenje gljivičnih infekcija), fluvoksamin (antidepresiv) i tiklopidin (koristi se za smanjenje rizika od moždanog udara).
English: In an investigator sponsored, randomized open-label multicenter study with blinded endpoint adjudication, rivaroxaban was compared to warfarin in patients with a history of thrombosis, diagnosed with antiphospholipid syndrome and at high risk for thromboembolic events (positive for all 3 antiphospholipid tests: lupus anticoagulant, anticardiolipin antibodies, and anti-beta 2-glycoprotein I antibodies).
Croatian: U randomiziranom, multicentričnom otvorenom ispitivanju sponzoriranom od strane ispitivača, sa zaslijepljenom procjenom mjera ishoda, rivaroksaban je uspoređen s varfarinom u bolesnika s anamnezom tromboze kojima je dijagnosticiran antifosfolipidni sindrom te imaju visok rizik od tromboembolijskih događaja (pozitivni na sva tri testa za antifosfolipidni sindrom: lupus antikoagulans, antikardiolipinska antitijela i anti-beta2-glikoprotein-I antitijela).
English: It is not known if your medicine may harm your unborn baby.
Croatian: Nije poznato može li ovaj lijek štetiti
English: Selective serotonin reuptake inhibitors: citalopram; escitalopram - Drug interaction with fluconazole (EPITT no
Croatian: Selektivni inhibitori ponovne pohrane serotonina: citalopram; escitalopram - interakcija lijeka s flukonazolom (EPITT br. 19327)
English: What you need to know before you take [Product name] Other medicines and [Product name]
Croatian: Što morate znati prije nego počnete uzimati [naziv lijeka]
English: No events were reported in patients randomized to warfarin.
Croatian: U bolesnika randomiziranih u skupinu koja je primala varfarin nije bilo prijavljenih događaja.
English: Direct-acting oral anticoagulants (DOACs): apixaban; dabigatran etexilate; edoxaban; rivaroxaban - Recurrent thrombosis in patients with antiphospholipid syndrome (EPITT no 19320)
Croatian: Direktno djelujući oralni antikoagulansi (DOAC): apiksaban; dabigatraneteksilat; edoksaban; rivaroksabanrekurentna tromboza u bolesnika s antifosfolipidnim sindromom (EPITT br. 19320)
English: In particular for patients that are triple positive (for lupus anticoagulant, anticardiolipin antibodies, and anti-beta 2-glycoprotein I antibodies), treatment with DOACs could be associated with increased rates of recurrent thrombotic events compared with vitamin K antagonist therapy.
Croatian: Posebice se ne preporučuju u bolesnika koji su trostruko pozitivni (na lupus antikoagulans, antikardiolipinska antitijela i anti-beta2glikoprotein-I antitijela), u kojih bi liječenje direktno djelujućim oralnim antikoagulansima moglo biti povezano s povećanom stopom rekurentnih trombotskih događaja u usporedbi s terapijom antagonistima vitamina K.
English: 4.5 Interaction with other medicinal products and other forms of interaction Thus, caution should be exercised when used concomitantly with CYP2C19 inhibitors (e.g. omeprazole, esomeprazole, fluconazole, fluvoxamine, lansoprazole, ticlopidine) or cimetidine.
Croatian: Zbog toga je potreban oprez pri istodobnoj primjeni s inhibitorima CYP2C19 (npr. omeprazol, esomeprazol, flukonazol, fluvoksamin, lanzoprazol, tiklopidin) ili cimetidinom.
English: Direct acting Oral Anticoagulants (DOACs) including rivaroxaban/apixaban/edoxaban/dabigatran etexilate are not recommended for patients with a history of thrombosis who are diagnosed with antiphospholipid syndrome.
Croatian: Direktno djelujući oralni antikoagulansi (engl. direct acting oral anticoagulants, DOAC), uključujući rivaroksaban/apiksaban/edoksaban/ dabigatraneteksilat, ne preporučuju se bolesnicima koji u anamnezi imaju trombozu a dijagnosticiran im je antifosfolipidni sindrom.
English: Rivaroxaban/dabigatran etexilate
Croatian: Rivaroksaban/dabigatraneteksilat
English: Major bleeding occurred in 4 patients (7%) of the rivaroxaban group and 2 patients (3%) of the warfarin group.
Croatian: U 4 bolesnika (7%) iz skupine koja je primala rivaroksaban i 2 bolesnika (3 %) iz skupine koja je primala varfarin došlo je do velikog krvarenja.
English: Fertility, pregnancy and lactation
Croatian: Sažetak opisa svojstava lijeka 4.6 Plodnost, trudnoća i dojenje
English: If you know that you have a disease called antiphospholipid syndrome (a disorder of the immune system that causes an increased risk of blood clots), tell your doctor who will decide if the treatment may need to be changed.
Croatian: Budite posebno oprezni s lijekom Eliquis/Lixiana/Roteas Ako znate da imate bolest koja se naziva antifosfolipidni sindrom (poremećaj imunološkog sustava koji uzrokuje povećani rizik od nastanka krvnih ugrušaka), obavijestite o tome svog liječnika koji će odlučiti postoji li potreba za izmjenom terapije.
English: Apixaban/edoxaban
Croatian: Rivaroksaban
English: An updated RMP shall be submitted by 31 October 2019.
Croatian: Ažurirani RMP bit će predan do 31. listopada 2019.
English: Tumour size 2 cm >2 cm
Croatian: Veličina tumora 2 cm >2 cm
English: a From the GETUG AFU15 study
Croatian: Iz studije GETUG AFU15
English: TAXOTERE contains alcohol.
Croatian: TAXOTERE sadrži alkohol.
English: • 2 years.
Croatian: • 2 godine.
English: UNIQUE IDENTIFIER - 2D BARCODE Not applicable
Croatian: JEDINSTVENI IDENTIFIKATOR - 2D BARKOD Nije primjenjivo
English: You must not be given TAXOTERE:
Croatian: TAXOTERE se ne smije primijeniti:
English: What TAXOTERE is and what it is used for
Croatian: Što je TAXOTERE i za što se koristi
English: The name of this medicine is TAXOTERE.
Croatian: Ovaj lijek se zove TAXOTERE.
English: STAMPEDE study
Croatian: STAMPEDE studija
English: None of these increases in frequency reached 10% difference with the control arm.
Croatian: Niti jedno od ovih povećanja učestalosti nije doseglo 10% razlike u odnosu na kontrolnu skupinu.
English: Please tell your doctor or hospital pharmacist if you are taking or have recently taken any other medicine, including medicines obtained without a prescription.
Croatian: Obavijestite svog liječnika ili ljekarnika ako uzimate ili ste nedavno uzeli bilo koje druge lijekove, uključujući i one koje ste nabavili bez recepta.
English: CHAARTED study
Croatian: CHAARTED studija
English: • if the number of white blood cells is too low.
Croatian: • ako imate premali broj bijelih krvnih stanica.
English: Other medicines and TAXOTERE
Croatian: Drugi lijekovi i TAXOTERE
English: The safety and efficacy of TAXOTERE in nasopharyngeal carcinoma in children aged 1 month to less than 18 years have not yet been established.
Croatian: Sigurnost primjene i djelotvornost lijeka TAXOTERE u nazofaringealnom karcinomu u djece starosti od 1 mjeseca do 18 godina nije još ustanovljena.
English: • 3 years.
Croatian: • 3 godine.
English: Date of first authorisation: 27 November 1995 Date of latest renewal: 27 November 2005
Croatian: Datum prvog odobrenja: 27. studeni 1995.
English: What you need to know before you use TAXOTERE
Croatian: Što morate znati prije nego počnete primati TAXOTERE
English: Hazard ratio (TAC/FAC)
Croatian: Omjer hazarda (TAC/FAC)
English: Summary of the safety profile for all indications
Croatian: Sažetak profila sigurnosti primjene lijeka za sve indikacije
English: a Time to event variables: Stratified log-rank test.
Croatian: a Varijable vremena do događaja: Stratificirani log-rang test.
English: In case of
Croatian: U pojedinim slučajevima
English: FORMULATION
Croatian: FORMULACIJA
English: See accompanying preparation guide.
Croatian: Vidjeti priložene upute za pripremu.
English: TAXOTERE will be given by infusion into one of your veins (intravenous use).
Croatian: TAXOTERE ćete dobiti infuzijom u jednu od vena (intravenska primjena).
English: (26.8-ne) TTP = time to progression; “ne” indicates that it could not be estimated or it was not yet reached.
Croatian: (26,8-ne) TTP = vrijeme do progresije bolesti; "ne" pokazuje da se nije moglo procijeniti ili da još nije bilo dostignuto potpuna analiza (intent-to-treat) procijenjeni medijan preživljenja
English: What TAXOTERE is and what it is used for What you need to know before you use TAXOTERE How to use TAXOTERE
Croatian: Što je TAXOTERE i za što se koristi Što morate znati prije nego počnete primati TAXOTERE
English: Frequencies are defined as: very common (≥ 1/10), common (≥ 1/100 to < 1/10); uncommon (≥ 1/1,000 to < 1/100); rare (≥ 1/10,000 to < 1/1,000); very rare (< 1/10,000); not known (cannot be estimated from available data).
Croatian: Učestalosti su definirane kao: vrlo često (≥1/10); često (≥1/100 i <1/10); manje često (≥1/1000 i <1/100); rijetko (≥1/10 000 i <1/1000); vrlo rijetko (<1/10 000); nepoznato (učestalost se ne može procijeniti iz dostupnih podataka).
English: The marketing authorisation holder shall submit PSUR for this product in accordance with the requirements set out in the list of Union reference dates (EURD list) provided for under Article 107c(7) of Directive 2001/83/EC and published on the European medicines web-portal.
Croatian: Nositelj odobrenja će podnositi PSUR za ovaj lijek u skladu s referentnim popisom datuma EU (EURD popis) predviđenim člankom 107.c stavkom 7. Direktive 2001/83/EZ i objavljenim na europskom internetskom portalu za lijekove.
English: Response rate variables: Fisher's Exact test * p-value for descriptive purpose.
Croatian: Varijable stope odgovora: Fisherov egzaktni test * p-vrijednost u opisne svrhe.
English: • infections, decrease in the number of red (anaemia), or white blood cells (which are important in fighting infection) and platelets
Croatian: • infekcije, smanjenje broja crvenih krvnih stanica (anemija) ili bijelih krvnih stanica (koje su važne u borbi protiv infekcija) i krvnih pločica
English: Histological grade Grade1 (includes grade not assessed) Grade 2
Croatian: Histološki gradus Gradus 1 (uključujući neodređeni gradus) Gradus 2
English: If this happens, do not drive or use any tools or machines before discussing with your doctor, nurse or hospital pharmacist.
Croatian: Ako se to dogodi, nemojte upravljati vozilima niti koristiti bilo kakve alate ili strojeve prije savjetovanja s vašim liječnikom, medicinskom sestrom ili bolničkim ljekarnikom.